mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.005 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.008 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.008 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |